Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Targeting the brain with Curcumin: Can we treat Chronic Traumatic Encephalopathy?
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory...
How do chemical exposures trigger autoimmune diseases?
The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...
Can a crocodile cure your ills? Testing the Crocodylus Apothecary Hypothesis
Why did alchemists hang crocodiles from the ceilings of their shops? Why did ancient Egyptians worship crocodiles...